134 related articles for article (PubMed ID: 8713780)
1. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
2. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo.
Orthner CL; Kolen B; Drohan WN
Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267
[TBL] [Abstract][Full Text] [Related]
3. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
4. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients.
Matsumoto K; Yano Y; Gabazza EC; Araki R; Bruno NE; Suematsu M; Akatsuka H; Katsuki A; Taguchi O; Adachi Y; Sumida Y
Diabet Med; 2007 Dec; 24(12):1322-8. PubMed ID: 17971179
[TBL] [Abstract][Full Text] [Related]
7. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
8. Low level of circulating activated protein C is a risk factor for venous thromboembolism.
España F; Vayá A; Mira Y; Medina P; Estellés A; Villa P; Falcó C; Aznar J
Thromb Haemost; 2001 Dec; 86(6):1368-73. PubMed ID: 11776301
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
10. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
[TBL] [Abstract][Full Text] [Related]
11. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
Marlar RA; Kressin DC; Madden RM
Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
[TBL] [Abstract][Full Text] [Related]
12. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.
Bakoush O; Ohlin AK; Strandberg K; Kurkus J
Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
14. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
Shen L; Villoutreix BO; Dahlbäck B
Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
[TBL] [Abstract][Full Text] [Related]
16. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
17. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
18. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex.
Bhiladvala P; Strandberg K; Stenflo J; Holm J
Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
[TBL] [Abstract][Full Text] [Related]
20. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
